All News about Bristol-Myers Squibb
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
September 14, 2022
Via Benzinga
Via Benzinga
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
Via Benzinga
Bristol Myers Squibb to Report Results for Third Quarter 2022 on October 26, 2022
September 07, 2022
From Bristol Myers Squibb
Via Business Wire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|